Dragging Oncogenes From the Cell: A New Horizon for Targeting KRAS
This Trojan horse-like treatment strategy may help neutralize undruggable cancer drivers.
Tag: KRAS
This Trojan horse-like treatment strategy may help neutralize undruggable cancer drivers.
Outside the lab, Frank McCormick, PhD, FAACR, is a racecar driver, nurturing a passion he developed decades ago. (“We...
Once considered undruggable, mutant KRAS has emerged in recent years as a viable target for anticancer therapeutics. As a...
After three decades of failed efforts to target the elusive KRAS and its family members NRAS and HRAS, proto-oncogenes...